Fig. 3From: Improvement in asymmetric dimethylarginine and oxidative stress in patients with limb salvage after autologous mononuclear stem cell application for critical limb ischemiaDecrease in ADMA concentration in relation to the number of delivered BM-MNCs at 3 months after cell delivery. ADMA asymmetric dimethylarginine, BM-MNC bone marrow-derived mononuclear cellBack to article page